CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 279 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $309,287,000 | +49.8% | 3,072,898 | -1.3% | 0.08% | +31.0% |
Q3 2014 | $206,448,000 | -0.9% | 3,111,973 | +4.3% | 0.06% | -1.7% |
Q2 2014 | $208,256,000 | -0.3% | 2,982,750 | +4.5% | 0.06% | -4.8% |
Q1 2014 | $208,882,000 | +5.7% | 2,855,525 | -0.5% | 0.06% | +3.3% |
Q4 2013 | $197,649,000 | +30.8% | 2,869,891 | +20.7% | 0.06% | +17.6% |
Q3 2013 | $151,059,000 | +17.2% | 2,377,016 | -10.9% | 0.05% | +8.5% |
Q2 2013 | $128,875,000 | – | 2,668,771 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |